Aspire Private Capital’s Bright Minds Biosciences DRUG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-100
| Closed | -$117 | – | 292 |
|
|
2024
Q3 | $117 | Hold |
100
| – | – | ﹤0.01% | 652 |
|
|
2024
Q2 | $108 | Hold |
100
| – | – | ﹤0.01% | 667 |
|
|
2024
Q1 | $120 | Hold |
100
| – | – | ﹤0.01% | 699 |
|
|
2023
Q4 | $143 | Hold |
100
| – | – | ﹤0.01% | 680 |
|
|
2023
Q3 | $160 | Buy |
+100
| New | +$160 | ﹤0.01% | 676 |
|
|
2023
Q2 | – | Sell |
-100
| Closed | -$220 | – | 679 |
|
|
2023
Q1 | $220 | Hold |
100
| – | – | ﹤0.01% | 621 |
|
|
2022
Q4 | $370 | Hold |
100
| – | – | ﹤0.01% | 608 |
|
|
2022
Q3 | $1K | Hold |
100
| – | – | ﹤0.01% | 552 |
|
|
2022
Q2 | $0 | Hold |
100
| – | – | ﹤0.01% | 614 |
|
|
2022
Q1 | $1K | Hold |
100
| – | – | ﹤0.01% | 538 |
|
|
2021
Q4 | $2K | Buy |
+100
| New | +$2K | ﹤0.01% | 511 |
|